KDM5B and melanoma: Later, the same group examined whether the subpopulation of JARID1Bhigh slow-cycling melanoma cells displayed a lower drug susceptibility compared to that of the bulk of tumor cells, discovering that JARID1B promotes melanoma intrinsic drug resistance via mitochondrially controlled reprogramming and the alteration of ROS production [96].